Advertisement

Topics

SK Capital to acquire Perrigo’s Israeli API business

05:42 EDT 11 Aug 2017 | Pharmaceutical Business Review

New York-based private investment firm SK Capital has agreed to acquire Perrigo API, the active pharmaceutical ingredients (API) business of Perrigo Company in Israel, for $110m in an all-cash deal.

Original Article: SK Capital to acquire Perrigo’s Israeli API business

NEXT ARTICLE

More From BioPortfolio on "SK Capital to acquire Perrigo’s Israeli API business"

Quick Search
Advertisement